본문으로 건너뛰기
← 뒤로

Oral Plasmablastic Lymphoma: Case Series and Literature Review.

증례연속 1/5 보강
Head & neck 2025 Vol.47(12) p. 3429-3442
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
11 cases of oral cavity PBL (OPBL) managed at our institution, detailing clinical, radiological, pathological, and therapeutic features, as well as patient outcomes.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Prognosis, however, remains poor. [CONCLUSIONS] OPBL should be systematically considered when evaluating oral cavity malignancy, especially in immunocompromised patients with submucosal lesion.

Xu A, Foy JP, Reimbold P, Amor-Sahli M, Vozy A, Boussen I, Chaine A, Benassarou M, Bertolus C, Bouaoud J

📝 환자 설명용 한 줄

[BACKGROUND] Plasmablastic lymphoma (PBL) of the oral cavity is a rare, aggressive subtype of Non-Hodgkin lymphoma, predominantly seen in immunocompromised patients, particularly those with chronic Hu

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Xu A, Foy JP, et al. (2025). Oral Plasmablastic Lymphoma: Case Series and Literature Review.. Head & neck, 47(12), 3429-3442. https://doi.org/10.1002/hed.70053
MLA Xu A, et al.. "Oral Plasmablastic Lymphoma: Case Series and Literature Review.." Head & neck, vol. 47, no. 12, 2025, pp. 3429-3442.
PMID 41025371
DOI 10.1002/hed.70053

Abstract

[BACKGROUND] Plasmablastic lymphoma (PBL) of the oral cavity is a rare, aggressive subtype of Non-Hodgkin lymphoma, predominantly seen in immunocompromised patients, particularly those with chronic Human Immunodeficiency Virus (HIV) infection. This malignancy is closely associated with Epstein-Barr virus (EBV), highlighting its oncogenic role.

[METHODS] We present 11 cases of oral cavity PBL (OPBL) managed at our institution, detailing clinical, radiological, pathological, and therapeutic features, as well as patient outcomes. We also conducted a comprehensive literature review to synthesize current evidence.

[RESULTS] Since 2008, 645 OPBL cases have been reported. The disease primarily affects men with underlying immunodeficiency, particularly HIV. The maxillary alveolar ridge was the most frequent subsite, typically associated with osteolytic bone lesions. Most patients presented at a localized stage. Although chemotherapy remains the mainstay of treatment, novel targeted therapies are emerging. Prognosis, however, remains poor.

[CONCLUSIONS] OPBL should be systematically considered when evaluating oral cavity malignancy, especially in immunocompromised patients with submucosal lesion.

MeSH Terms

Adult; Aged; Humans; Male; Middle Aged; HIV Infections; Immunocompromised Host; Mouth Neoplasms; Plasmablastic Lymphoma; Prognosis

같은 제1저자의 인용 많은 논문 (5)